Changes to the Board of Directors at PZ Cussons

PZ Cussons plc has appointed two non executive directors to its board: Helen Owers and Ngozi Edozien. They will join the board on Jan. 1, 2012.

Owers is chief development officer for Thomson Reuters Professional, with responsibility for the company’s expansion in rapidly developing economies.

Edozien is chief executive, West Africa at Actis, a leading private equity investor in emerging markets, where she is responsible for all aspects of the company’s business in the region. Prior to joining Actis, Ngozi was VP strategic planning and business development for Pfizer Inc. based in New York where she drove the financial and strategic planningprocesses of the company in addition to leading strategy projects and transactions for Pfizer. She was transferred to Nigeria in 2005 to run Pfizer’s businesses in East, West and Central Africa, before being appointed in 2008 as chief executive of the Equity Vehicle for Health in Africa, an investment company focused on investing in private healthcare businesses in the continent.

‘We are delighted to welcome Helen and Ngozi to the Board. They each bring with them a wealth of relevant experienceand insights which will be very valuable as we continue to grow the business,” noted Richard Harvey, chairman of PZ Cussons. “Their appointments will also serve to make the Board more representative of the Group’s geographic profile and its customer base and reflect our belief in the benefits of diversity – in the Boardroom and across the whole of the Group.”

Derek Lewis, who was appointed to the board as a non-executive director in 2004 and has served as senior independent director since 2008, will retire from the board in September 2012.